Nomura Code Appoints Jonathan Senior to Corporate Finance Role
London, 23 July, 2007 – Nomura Code Securities Limited ("Nomura Code"), the specialist life sciences investment bank, today announces the appointment of Dr. Jonathan Senior as Director, Corporate Finance with immediate effect.
Having started his career in the medical profession, Dr. Senior moved across to the financial services sector some nine years ago. He joins Nomura Code from Evolution Securities where he was Head of Life Sciences Equity Research. Prior to that, he was at Credit Suisse First Boston where he worked both as a member of the Healthcare Corporate Finance team and was a key member of their number one ranked Biotech Equity Research team1.
Commenting on the appointment, Chris Collins, CEO of Nomura Code, said: "We are delighted to welcome Jonathan to the corporate finance team, which now comprises of 15 specialist advisers. Jonathan is very experienced, extremely well-connected and highly respected within the life sciences sector. "Such an important addition to Nomura Code underlines our commitment to hiring the best specialists in the life sciences field in order to service our clients' needs and to expand our business."
Dr. Jonathan Senior commented: "I am very excited to be joining Nomura Code. When I took the decision to move on I was only interested in working for the leader in the life sciences sector. Nomura Code is the best placed firm in this space with an attractive growth prospect, entrepreneurial culture and an excellent track record in both M&A and financing transactions."
Nomura Code has the largest and most experienced sector team in Europe, having executed over 100 life sciences financing transactions, including 37 IPOs, raising more than €3.7 billion.
Recent Nomura Code deals:
June 2007:
Transgene S.A: Co-Lead Manager for a Secondary Issue to raise €100 million.
May 2007:
XCounter ABL: Nominated Adviser and Broker for a £15.0 million Cash Placing and Placing and Open Offer on AIM.
Tyratech, Inc.: Nominated Adviser and Lead Underwriter for an IPO raising £25 million.
April 2007:
Agcert International plc: Joint Underwriter for a Share Placing to raise £20.5 million and capitalisation of £10 million of debt to finance revised business strategy.
March 2007:
Minster Pharmaceuticals plc: Nominated Adviser and Broker for a Share Placing to raise £17 million.
Notes:
1. The CSFB Team was ranked number 1 by Institutional Investor for three-years between 2000-2002.
Ends
For further information please contact:
 |
||
| Name | Company | Telephone |
|
||
| Chris Collins | CEO Nomura Code Securities |
00 44 (0) 20 7776 1200 |
| Allister Fowler | Corporate Communications Nomura International plc |
00 44 (0) 20 7521 2442 |
|
||
Notes to editors:
The Nomura Group
Nomura is a global financial services group dedicated to providing a broad range of financial services for individual, institutional, corporate and government clients. The Group offers a diverse line of competitive products and value-added financial and advisory solutions through its global headquarters in Tokyo, over 150 branches in Japan, and an international network in 30 countries; with regional headquarters in Hong Kong, London, and New York. The Group's business activities include investment consultation and brokerage services for retail investors in Japan, and, on a global basis, brokerage services, securities underwriting, investment banking advisory services, merchant banking, and asset management. For further information about Nomura please visit our website at www.nomura.com.
Nomura Code Securities Limited
Nomura Code is a recognised leader in the life sciences sector and offers a dedicated entrepreneurial team with big bank experience; the strongest sector-specific research and sales team with eight analysts, four salespeople and three sales traders; the most experienced industry-focused corporate finance team; and commitment at all levels to its clients' needs. Nomura Code has executed over 100 life sciences financing transactions, including 37 IPOs, raising more than €3.7 billion. www.codesecurities.com
